Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
Wong, Waichi
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. [electronic resource] - Clinical transplantation Aug 2004 - 341-8 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0902-0063
10.1111/j.1399-0012.2004.00171.x doi
Adult
Blood Pressure
C-Reactive Protein--analysis
Cardiovascular Diseases--epidemiology
Cyclosporine--administration & dosage
Female
Graft Survival
Homocysteine--blood
Humans
Immunosuppressive Agents--administration & dosage
Kidney Function Tests
Kidney Transplantation
Male
Mycophenolic Acid--analogs & derivatives
Postoperative Period
Prednisolone--therapeutic use
Prospective Studies
Risk Assessment
Risk Factors
Uric Acid--blood
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. [electronic resource] - Clinical transplantation Aug 2004 - 341-8 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0902-0063
10.1111/j.1399-0012.2004.00171.x doi
Adult
Blood Pressure
C-Reactive Protein--analysis
Cardiovascular Diseases--epidemiology
Cyclosporine--administration & dosage
Female
Graft Survival
Homocysteine--blood
Humans
Immunosuppressive Agents--administration & dosage
Kidney Function Tests
Kidney Transplantation
Male
Mycophenolic Acid--analogs & derivatives
Postoperative Period
Prednisolone--therapeutic use
Prospective Studies
Risk Assessment
Risk Factors
Uric Acid--blood